Robert Baffi

Robert Baffi

Corporate Officer/Principal at SAMSARA INC.

Net worth: - $ as of 31/05/2026

71 year
Health Technology
Consumer Services
Technology Services

Profile

Robert A. Baffi is Director at the National Institute for Bioprocessing Research & Training.
He is Director at Neurogene, Inc. (New York) since 2020 and Independent Director at Neurogene, Inc. since 2023.
He is Venture Partner at Samsara BioCapital LLC and Samsara, Inc., both since 2021.
Former roles include Director at Genentech, Inc. in 2000, Director at Humanigen, Inc. from 2014 to 2015, Director at Bionic Sight, Inc. from 2020 to 2024, Independent Director at Mosaic ImmunoEngineering, Inc., Executive Vice President-Technical Operations at BioMarin Pharmaceutical, Inc. from 2010 to 2020, and Research Scientist at Cooper Biomedical, Inc. Education includes undergraduate, graduate, and doctorate degrees from City University of New York conferred in 1983, and an MBA from Regis University conferred in 2001.

Known holdings in public companies

CompanyDateNumber of sharesValuationValuation date
-.--%
07/04/2026 0 ( -.--% ) - $ 31/05/2026
31/03/2025 0 ( -.--% ) - $ 31/05/2026

Robert Baffi active positions

CompaniesPositionStart
SAMSARA INC. Corporate Officer/Principal 01/03/2021
Director/Board Member -
Director/Board Member 17/09/2020
Private Equity Investor 01/03/2021

Former positions of Robert Baffi

CompaniesPositionEnd
BIOMARIN PHARMACEUTICAL INC. Corporate Officer/Principal 04/05/2020
HUMANIGEN, INC. Director/Board Member 20/11/2015
Director/Board Member 01/01/2000
MOSAIC IMMUNOENGINEERING, INC. Director/Board Member -
See the detail of Robert Baffi's experience

Training of Robert Baffi

Experiences
Positions held

Active

Inactive

Listed companies

Private companies

Connections

87

1st degree connections

11

1st degree companies

Male

Female

Members of the board

Executives

Linked companies

Private companies11

Health Technology

Health Technology

Health Technology

Consumer Services

Consumer Services

Health Technology

Health Technology

Technology Services

Finance

Health Technology

Health Technology

-40%: Exceptional extension
d
:
:
SEIZE THE OFFER!